Support our Foundation of Myology project
1655 news items
A natural microRNA spiked with small molecules to knock down DUX4 in FSHD
On 14/03/2022
Facioscapulohumeral muscular dystrophy (FSHD or FSH) is characterized by an aberrant expression of the DUX4 gene. To prevent it, in a gene silencing approach, a…
Myasthenia gravis: launch of the MYaEX study
On 14/03/2022
The Institute of Myology and AFM-Telethon have launched MYaEX, a large national survey regarding persons with myasthenia gravis, congenital myasthenic syndrome or Lambert Eaton myasthenic syndrome. …
Searching for protective factors against cancer risk in dermatomyositis
On 11/03/2022
American researchers were interested in patients with dermatomyositis who did not develop cancers in addition to their muscle disease. Their immunological profile has been studied…
Systemic injection of an optimized antisense oligonucleotide into an FSH mouse model appears to be effective
On 10/03/2022
Facioscapulohumeral dystrophy (FSH) is one of the most common myopathies. There are two forms, FSH1 and FSH2. In both cases, the DUX4 gene is abnormally…
A catalog of sodium channel variants to guide in the diagnosis of certain myotonic syndromes
On 09/03/2022
An international consortium of researchers has catagorized, based on literature data, the biophysical and genetic characteristics of 437 sodium channel variants known to date (including…
An innovative test for the genotyping of difficult cases of DMD and a better pathophysiological approach
On 08/03/2022
Italian researchers have developed, in conjunction with the Perkin-Elmer laboratory, a test based on RNA sequencing (RNA-seq) to detect and interpret the pathogenic nature of…
Gastrointestinal motility disorders may accompany dermatomyositis
On 08/03/2022
Publishing a study on a case, a team of Texan internists recalls the possibility of various digestive motor disorders in dermatomyositis: proximal dysphagia (pharynx and…
No beneficial effect of resveratrol in fatty acid oxidation disorders
On 07/03/2022
Resveratrol has been studied in a randomized, placebo-controlled, cross-over clinical trial. Organized jointly by French, Danish and Dutch, the study aimed to measure possible positive…
A compilation of data on primary carnitine deficiencies
On 03/03/2022
A review of the literature carried out by Dutch authors sheds light on the symptoms and signs, often disparate, associated with this metabolic disease discovered…
Update on hematological abnormalities in neuromuscular genetic pathologies
On 02/03/2022
American researchers examined the presence and type of blood abnormalities existing in certain hereditary myopathies. These abnormalities may be of interest for the positive diagnosis,…
Glucocorticoids more helpful for breathing than for the heart past loss of walking ability in DMD
On 01/03/2022
American clinicians have been trying to find out if long-term corticosteroid therapy in DMD could be of any use in the non-ambulatory stage of the…
Variety of practices in the cardiac management of patients with DMD
On 28/02/2022
American cardio-paediatricians gathered within the ACTION network (Advanced Cardiac Therapies Improving Outcomes Network) were questioned about their management practices concerning DMD: 31 specialists from 23…
High-throughput genomic sequencing (NGS) proves reliable for detecting deletions of the SMN1 gene
On 25/02/2022
Chinese researchers associated with the Beijing Genomics Institute (BGI) compared three molecular biology techniques to detect the number of copies of the SMN1 gene in…
An online survey of genetic information in relatives
On 24/02/2022
As part of the IGP rare project, which emanates from a collective bringing together health professionals, researchers and patient associations, an online survey was launched…
Plasma biomarkers in myositis ossificans
On 24/02/2022
Myositis ossificans or fibrodysplasia ossificans progressive (FOP) is an ultra-rare genetic disease associating progressive ankylosis and malformative bone abnormalities. American researchers have identified several biomarkers…
A meta-analysis confirms the increase of 10 years in life expectancy in DMD
On 24/02/2022
A team of British and Swedish researchers calculated the life expectancy of persons with Duchenne muscular dystrophy (DMD) from individual survival data extracted from survival…
Intranuclear inclusions in oculo-pharyngo-distal myopathy (OPDM)
On 23/02/2022
Oculopharyngodistal myopathy (OPDM) is an ultra-rare autosomal dominant neuromuscular disease in which abnormal CGG-like nucleotide repeats have been identified in three genes (NOTCH2NLC, GIPC1, LRP12).…
Evaluation of Fitbit® connected bracelets in NMD
On 22/02/2022
A study compared two Fitbit® smartwatch models and medical devices (accelerometer, heart monitor, etc.) frequently used in clinical trials, in 110 people with neuromuscular diseases:…
mRNA vaccines in MNM: a satisfactory response despite muscle atrophy
On 21/02/2022
An American team studied the impact of muscle atrophy and corticosteroid therapy on the immune response to messenger RNA (mRNA) vaccines against SARS-CoV-2 in 14…
An inventory of tools used in the assessment of neuromuscular patients
On 21/02/2022
Italian clinicians have compiled data from the literature published between 2000 and 2021 concerning the technological assessment tools used, routinely or during trials, in neuromuscular…